Premier Health of America Inc (PHA) AI Stock Analysis

• Market Cap: C$3.77M
• Dividend Yield: N/A
• Average Volume (3M): 29.21K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.28
• Revenue Growth: 3.03%
• EPS Growth: -410.90%
• Country: CA
• Employees: 589
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Care Facilities
• EPS (TTM): -0.06
• Shares Outstanding: 55,514,153
• 10 Day Avg. Volume: 20,891
• 30 Day Avg. Volume: 29,212
• PEG Ratio: 0.01
• Price to Book (P/B): 2.25
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 1.14
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: C$0.00 ▼(-100.00%Downside)

The overall stock score reflects significant financial and operational challenges, with high leverage and negative valuation metrics. Technical analysis shows bearish trends, compounded by recent corporate events indicating strategic reorientation amidst financial struggles.

Premier Health of America Inc Business Overview & Revenue Model

Company Description

Premier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities, as well as medical transport services; and Code Bleu, an agency to employ nurses, caregivers, dental staff, and other health-related personnel. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company was founded in 2003 and is headquartered in Blainville, Canada.

How the Company Makes Money

Premier Health of America Inc generates revenue primarily through its staffing and outsourcing services within the healthcare sector. The company earns money by supplying qualified healthcare professionals, such as nurses and support staff, to healthcare facilities that require additional workforce support. These services are typically billed on a contractual or per-hour basis, depending on the needs of the client. PHA also engages in partnerships with various healthcare institutions to provide tailored staffing solutions, which contribute significantly to its earnings. Additionally, the company's focus on efficient service delivery and maintaining strong client relationships aids in sustaining long-term revenue streams.

Premier Health of America Inc Financial Statement Overview

Summary

The company faces financial hurdles with declining profitability and increasing leverage. The income statement reflects operational inefficiencies and revenue volatility, while the balance sheet indicates high leverage and reduced equity. Cash flow improvements provide some hope, but sustained efforts are needed to stabilize financial performance.

Income Statement

Premier Health of America Inc shows declining revenue with a negative net income in the TTM period, indicating financial challenges. Gross profit margin has decreased, and negative EBIT and EBITDA margins signal struggles in operational efficiency. The revenue growth rate is fluctuating, with a significant increase from 2021 to 2023 but a recent decline in 2024.

Balance Sheet

The company has a high debt-to-equity ratio due to substantial debt levels compared to equity, highlighting financial risk. Return on Equity is negative due to net losses, and the equity ratio has declined significantly, indicating higher leverage and reduced financial stability.

Cash Flow

Positive operating cash flow in the TTM period suggests some operational strength despite net losses. Free cash flow has shown improvement recently, albeit from negative levels in previous years, indicating better capital expenditure management. However, the free cash flow to net income ratio is negatively impacted by net losses.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
153.35M	158.19M	90.39M	80.51M	66.63M	20.74M
	Gross Profit
21.54M	27.89M	23.34M	20.08M	16.25M	5.71M
	EBIT
-2.84M	-787.00K	3.33M	2.34M	3.44M	1.97M
	EBITDA
-2.01M	384.00K	5.87M	5.61M	5.90M	804.93K
	Net Income Common Stockholders
-14.52M	-12.49M	-1.70M	-111.51K	1.50M	27.92K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
37.00K	1.50M	1.15M	5.12M	2.68M	1.23M
	Total Assets
70.58M	73.72M	56.71M	57.09M	39.13M	8.72M
	Total Debt
51.83M	49.85M	27.27M	22.84M	12.30M	2.73M
	Net Debt
51.79M	48.36M	26.12M	17.71M	9.62M	1.50M
	Total Liabilities
68.74M	69.64M	40.27M	38.62M	21.81M	4.85M
	Stockholders Equity
1.85M	4.08M	16.44M	18.47M	17.32M	3.87M
Cash Flow		Free Cash Flow
3.66M	3.02M	-3.20M	3.38M	24.13K	479.20K
	Operating Cash Flow
6.65M	5.93M	-1.27M	4.04M	1.97M	804.89K
	Investing Cash Flow
-3.98M	-26.43M	-3.33M	-12.67M	-16.08M	894.94K
	Financing Cash Flow
-3.42M	20.85M	625.00K	11.07M	15.56M	-424.55K

Premier Health of America Inc Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.07
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PHA, the sentiment is Neutral. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.07, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.57 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:PHA.

Premier Health of America Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXE	73 Outperform	C$1.21B	15.80	71.61%	3.33%	9.38%	117.85%
SIA	72 Outperform	C$1.71B	43.83	6.93%	5.04%	8.76%	14.05%
NLH	72 Outperform	C$23.84M	20.68	4.53%	―	4.09%	―
CRRX	65 Neutral	C$173.09M	―	-4.48%	―	-0.69%	8.08%
Sector *	53 Neutral	$5.23B	3.23	-44.27%	2.82%	16.82%	0.11%
PHA	46 Neutral	C$3.77M	―	-239.50%	―	3.03%	-410.90%
MFCSF		$218.78M	2.41	33.87%	2.26%	―	―

Premier Health of America Inc Corporate Events

Premier Health of America Announces CFO Transition

Premier Health of America Inc. announced a transition in its CFO position, appointing Frédéric St-Cyr as the Interim Chief Financial Officer. This change follows the previous CFO, Guy Daoust, taking on the role of interim CEO. The appointment of St-Cyr, who has a strong background in finance and accounting, is expected to support the company during this transition period. This strategic move is likely to impact the company’s operations by ensuring continuity in financial leadership, which is crucial for maintaining its market position in the healthtech industry.

Premier Health of America Reports Q2 2025 Financial Results Amidst Market Challenges

Premier Health of America Inc. reported its second quarter 2025 financial results, highlighting a significant decline in revenues and adjusted EBITDA compared to the previous year, primarily due to decreased volumes in Quebec and British Columbia. The company is undergoing a reorganization, particularly in Quebec, to adapt to market conditions and regulatory impacts such as Quebec’s Bill 10, which has affected its Per Diem segment. Despite these challenges, Premier Health is focusing on cost reduction, debt management, and exploring growth opportunities in the Travel Nurses and Home Care sectors.

Premier Health of America Inc. Reports Shareholder Meeting Results

Premier Health of America Inc. announced that all matters proposed at its annual general meeting on April 30, 2025, were approved by shareholders. Key decisions included the re-appointment of Raymond Chabot Grant Thornton LLP as auditor, the election of board members Pierre-Luc Toupin, Hubert Marleau, and Jean-Robert Pronovost, and the continuation of the incentive Stock Option Plan. The meeting saw participation from shareholders holding 54.49% of the total issued and outstanding shares, indicating strong stakeholder engagement and support for the company’s strategic direction.